SynthesisArchives of dermatological research2025
The lip flip: a systematic review of botulinum toxin lip augmentation.
Synthesis in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lip Flip Revisited: Clinical Outcomes and Neuromodulatory Basis of Upper Lip Eversion.Aesthetic plastic surgery · 2026Article
- Botulinum Toxin for Lip Inversion in Gummy Smile.Cureus · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The cosmetic use of botulinum toxin type-A (BTA) has expanded to include the "lip flip" procedure, which enhances lip contour and fullness without adding volume. This minimally invasive and cost-effective technique offers a favorable safety profile for patients seeking subtle lip enhancement. This review systematically examines the technique, clinical outcomes, and safety of the lip flip through neuromodulation with BTA. A comprehensive literature search was conducted using PubMed and Ovid, identifying 48 articles, of which seven met inclusion criteria detailing injection sites and dosages. The procedure typically involves injecting 4-6 units of BTA into the orbicularis oris muscle, resulting in consistent upper lip eversion and improved contour. Patients report high satisfaction and minimal downtime, with mild and transient side effects such as difficulty whistling or drinking through straws resolving within weeks.
Indexed as
Identifiers
40377719What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.